International Journal of Cardiology Congenital Heart Disease
Scope & Guideline
Connecting global experts in congenital heart disease.
Introduction
Aims and Scopes
- Clinical Outcomes and Risk Assessment:
The journal consistently publishes studies that evaluate clinical outcomes in patients with congenital heart disease, assessing long-term survival, morbidity, and risk factors associated with various conditions. - Innovative Therapies and Surgical Techniques:
Research on new surgical techniques, catheter-based interventions, and pharmacological therapies is a core focus, highlighting advancements in treatment options for adult patients with congenital heart disease. - Patient-Centered Care and Quality of Life:
There is a strong emphasis on understanding the psychosocial impact of congenital heart disease, including studies on mental health, quality of life, and patient engagement in treatment decisions. - Epidemiology and Registry Studies:
The journal publishes research leveraging national and international registries to provide insights into the epidemiology of congenital heart disease, treatment trends, and outcomes across different populations. - Multidisciplinary Approaches to Care:
The journal supports the integration of various specialties in managing congenital heart disease, promoting studies that involve collaborative care models and the role of different healthcare professionals.
Trending and Emerging
- Telemedicine and Remote Care:
With the increasing reliance on telemedicine, especially during the COVID-19 pandemic, studies exploring the efficacy and patient experiences with remote care are gaining prominence. - Mental Health and Psychosocial Support:
There is a growing body of literature focusing on the mental health and psychosocial aspects of living with congenital heart disease, highlighting the importance of comprehensive care that addresses these needs. - Interdisciplinary Collaboration in Care:
Emerging studies emphasize the importance of interdisciplinary approaches to patient care, with a focus on how collaboration among cardiologists, surgeons, psychologists, and other health professionals can improve outcomes. - Longitudinal Studies and Life Course Perspectives:
Research examining the long-term outcomes and quality of life across different life stages is trending, reflecting a shift towards understanding the lifelong impact of congenital heart disease. - Innovative Diagnostic Tools and Techniques:
Recent publications are increasingly featuring studies on novel diagnostic approaches, including advanced imaging techniques and biomarkers, that enhance the management of congenital heart disease.
Declining or Waning
- Basic Science and Molecular Mechanisms:
Research focused on the basic science of congenital heart disease, including genetic and molecular studies, has seen a decrease in publication frequency, possibly as the field shifts towards clinical applications and outcomes. - Pediatric-Centric Studies:
As the journal has increasingly emphasized adult congenital heart disease, studies centered solely on pediatric populations are becoming less frequent, reflecting a broader trend towards lifelong care models. - Traditional Surgical Approaches:
There is a noticeable decline in publications relating to conventional surgical approaches, as the focus has shifted towards minimally invasive techniques and new technologies that enhance patient outcomes.
Similar Journals
THERAPEUTIC APHERESIS AND DIALYSIS
Innovating therapeutic strategies for better patient outcomes.THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.
JOURNAL OF CRANIOFACIAL SURGERY
Shaping the future of craniofacial surgery through rigorous research.JOURNAL OF CRANIOFACIAL SURGERY, published by Lippincott Williams & Wilkins, is a leading academic journal dedicated to the multidisciplinary field of craniofacial surgery. Since its inception in 1990, the journal has served as a vital platform for disseminating innovative research and clinical practices related to craniofacial disorders, surgical techniques, and advancements in otorhinolaryngology. With an ISSN of 1049-2275 and an E-ISSN of 1536-3732, it features rigorous peer-reviewed articles that appeal to both seasoned professionals and emerging scholars. Currently ranked Q2 in Surgery and Q3 in both Medicine and Otorhinolaryngology, it has established a reputation for high-quality publications, reflected in its Scopus rankings and consistent engagement from the research community. Despite not being an open-access journal, it remains vital in advancing knowledge and practice in craniofacial surgery, making it an essential resource for practitioners, researchers, and students aiming to stay at the forefront of this evolving discipline.
Frontiers in Cardiovascular Medicine
Pioneering Research in Cardiology and Beyond.Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.
CLINICAL AND EXPERIMENTAL MEDICINE
Connecting Researchers and Practitioners for Better HealthClinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.
Structural Heart-The Journal of the Heart Team
Elevating cardiovascular medicine, one study at a time.Structural Heart - The Journal of the Heart Team, published by Elsevier Science Inc, is a leading journal dedicated to advancing the field of cardiology and cardiovascular medicine. Since its inception in 2017, this journal has committed to providing high-quality, peer-reviewed research and clinical insights aimed at enhancing patient care and interdisciplinary collaboration among heart teams. With an impressive Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine, it positions itself in the upper tier of cardiovascular literature, supported by a robust Open Access model since 2022, enabling wider dissemination of knowledge. Covering a diverse range of topics including innovative treatment methodologies and latest outcomes in structural heart disease, this journal serves as an essential resource for researchers, clinicians, and students alike, fostering a deeper understanding of heart health and wellness.
Gastroenterology Report
Shaping the Future of Gastrointestinal Health Through ResearchGastroenterology Report, published by Oxford University Press, is a leading Open Access journal dedicated to advancing the field of gastroenterology. Since its inception in 2013, this journal has become a vital resource for researchers, clinicians, and students, providing them with access to high-quality, peer-reviewed articles that span a wide range of topics in gastrointestinal health and disease. With an impressive Q2 ranking in gastroenterology and holding a position of #66 out of 167 in Scopus rankings, it reflects the growing impact and relevance of its published research. The objective of the Gastroenterology Report is to foster interdisciplinary collaboration and disseminate crucial findings that can improve patient outcomes and shape future studies. As the journal converges its efforts from 2014 to 2024, it continues to strengthen its role as a premier outlet for innovative research and clinical advances in the dynamic field of gastroenterology.
Cirugia Cardiovascular
Uniting minds to reshape cardiovascular healthcare.Cirugia Cardiovascular is a distinguished open-access journal published by Elsevier, dedicated to advancing the field of cardiovascular surgery and medicine. Established in Spain, this journal serves as a vital platform for disseminating innovative research and clinical insights in the realms of cardiology and surgical practices. With its ISSN 1134-0096 and E-ISSN 1134-0096, Cirugia Cardiovascular has been making impactful contributions to the medical community since becoming an open-access publication in 2005, thus ensuring unrestricted access to critical knowledge. In the most recent evaluation, it was positioned in the Q4 category in both Cardiology and Cardiovascular Medicine and Surgery as of 2023, reflecting its ongoing commitment to improving its scholarly impact. Despite its current ranking within the Scopus database, which highlights its value at percentile ranks of 19th in Surgery and 12th in Cardiology and Cardiovascular Medicine, Cirugia Cardiovascular continues to embrace growth and innovation. The journal aims to unite researchers, clinicians, and students, fostering a collaborative environment to elevate cardiovascular healthcare practices. With a converged year range from 2012 to 2024, it optimally addresses contemporary challenges and advancements in cardiovascular surgical techniques and outcomes.
AMERICAN JOURNAL OF CARDIOLOGY
Leading the Charge in Cardiovascular Discovery and ExcellenceThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Cardiology and Therapy
Empowering clinicians with cutting-edge cardiovascular insights.Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.
Journal of the Saudi Heart Association
Exploring Innovations in Cardiology and Patient CareThe Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.